A detailed history of Sloy Dahl & Holst, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Sloy Dahl & Holst, LLC holds 12,392 shares of PFE stock, worth $326,653. This represents 0.06% of its overall portfolio holdings.

Number of Shares
12,392
Previous 8,342 48.55%
Holding current value
$326,653
Previous $233,000 53.65%
% of portfolio
0.06%
Previous 0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$27.7 - $31.39 $112,185 - $127,129
4,050 Added 48.55%
12,392 $358,000
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $23,365 - $27,380
925 Added 12.47%
8,342 $233,000
Q4 2023

Jan 30, 2024

BUY
$26.13 - $33.94 $13,613 - $17,682
521 Added 7.56%
7,417 $213,000
Q4 2022

Jan 30, 2023

SELL
$41.75 - $54.5 $21,334 - $27,849
-511 Reduced 6.9%
6,896 $353,000
Q3 2022

Oct 19, 2022

SELL
$43.76 - $53.42 $125,503 - $153,208
-2,868 Reduced 27.91%
7,407 $324,000
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $70,500 - $87,359
1,541 Added 17.64%
10,275 $531,000
Q3 2021

Nov 03, 2021

BUY
$39.25 - $50.42 $20,056 - $25,764
511 Added 6.21%
8,734 $376,000
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $4,847 - $5,491
135 Added 1.67%
8,223 $322,000
Q1 2021

May 12, 2021

BUY
$33.49 - $37.77 $31,246 - $35,239
933 Added 13.04%
8,088 $293,000
Q4 2020

Feb 08, 2021

BUY
$33.47 - $42.56 $55,225 - $70,224
1,650 Added 29.97%
7,155 $286,000
Q3 2020

Nov 13, 2020

BUY
$31.75 - $37.25 $174,783 - $205,061
5,505 New
5,505 $204,000
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $230,568 - $279,713
-7,655 Closed
0 $0
Q1 2020

May 12, 2020

BUY
$27.03 - $38.62 $13,515 - $19,310
500 Added 6.99%
7,655 $249,000
Q4 2019

Jan 21, 2020

BUY
$32.92 - $37.36 $235,542 - $267,310
7,155 New
7,155 $280,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Sloy Dahl & Holst, LLC Portfolio

Follow Sloy Dahl & Holst, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sloy Dahl & Holst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sloy Dahl & Holst, LLC with notifications on news.